Acute bacterial rhinosinusitis: A review of U.S. treatment guidelines
作者： Bradley F. Marple , Stephen Brunton , Berrylin J. Ferguson
DOI: 10.1016/J.OTOHNS.2005.12.021
关键词:
摘要: Acute bacterial rhinosinusitis (ABRS) is a common complication of viral upper respiratory tract infections and associated with significant socioeconomic burden. Guidelines for the diagnosis management ABRS have been produced in association number societies United States; these guidelines aim to promote rational selection antibiotic therapy optimize clinical outcomes while minimizing potential resistance. This article provides an overview current U.S. treatment ABRS, focusing on impact resistance options.
sagepub.com
elsevier.com
utsystem.edu参考文章(51)
Maynard Luterman, Guy Tellier, Benjamin Lasko, Bruno Leroy, Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear, nose, & throat journal. ,vol. 82, pp. 576- 590 ,(2003) , 10.1177/014556130308200812
Gómez-Lus Ml, Valero E, Prieto J, Calvo A, Amores R, Fuentes F, Activity of oral antibiotics against respiratory tract pathogens in Spain. Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia. ,vol. 16, pp. 436- ,(2003)
George G Zhanel, Maria Dueck, Daryl J Hoban, Lavern M Vercaigne, John M Embil, Alfred S Gin, James A Karlowsky, None, Review of macrolides and ketolides: focus on respiratory tract infections. Drugs. ,vol. 61, pp. 443- 498 ,(2001) , 10.2165/00003495-200161040-00003
, Antimicrobial treatment guidelines for acute bacterial rhinosinusitis Otolaryngology-Head and Neck Surgery. ,vol. 130, pp. 1- 45 ,(2004) , 10.1016/J.OTOHNS.2003.12.003
M Barza, N Terrin, E Balk, J Lau, D Zucker, EA Engels, D Liu, D Devine, Ta Lang, P Chew, Diagnosis and treatment of acute bacterial rhinosinusitis. Evidence report/technology assessment (Summary). pp. 1- 5 ,(1999)
J. M. Klossek, P. Federspil, Update on treatment guidelines for acute bacterial sinusitis International Journal of Clinical Practice. ,vol. 59, pp. 230- 238 ,(2005) , 10.1111/J.1742-1241.2005.00378.X
D. Felmingham, C. Feldman, W. Hryniewicz, K. Klugman, S. Kohno, D.E. Low, C. Mendes, A.C. Rodloff, Surveillance of resistance in bacteria causing community‐acquired respiratory tract infections Clinical Microbiology and Infection. ,vol. 8, pp. 12- 42 ,(2002) , 10.1046/J.1469-0691.8.S.2.5.X
Michael R Jacobs, Drug-resistant Streptococcus pneumoniae: rational antibiotic choices The American Journal of Medicine. ,vol. 106, pp. 19- 25 ,(1999) , 10.1016/S0002-9343(98)00351-9
Robertino M. Mera, Linda A. Miller, Justin J.D. Daniels, John G. Weil, Anthony R. White, Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagnostic Microbiology and Infectious Disease. ,vol. 51, pp. 195- 200 ,(2005) , 10.1016/J.DIAGMICROBIO.2004.10.009
Jasmanda H. Wu, David H. Howard, John E. McGowan, Lourdes M. Frau, Wanju S. Dai, Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumonia. Clinical Therapeutics. ,vol. 26, pp. 2153- 2162 ,(2004) , 10.1016/J.CLINTHERA.2004.12.016